Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias - Report - MDSpire

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

  • By

  • Dimitry S. Davydow

  • Gregory M. Pontone

  • Michael S. Okun

  • Melissa J. Armstrong

  • Theresa Wimberley Böttger

  • Camila Geels

  • Lise Marie Frohn

  • Jørgen Brandt

  • Julie Werenberg Dreier

  • Jakob Christensen

  • Carsten Bøcker Pedersen

  • Henriette Thisted Horsdal

  • May 14, 2026

  • 0 min

Share

Clinical Report: The Relationship Between Air Pollution and Dementias

Overview

Revise to specify the pollutants studied (PM2.5 and NO2) and their direct relevance to DLB and PDD.

Background

The incidence of α-synucleinopathies, including Parkinson's disease (PD), is rising, making it crucial to understand their epidemiology and potential environmental contributors. DLB and PDD account for a significant proportion of dementia cases globally, emphasizing the need for research into modifiable risk factors such as air pollution.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Long-term exposure to PM2.5 is associated with a 12% increased risk of hospitalization in DLB patients.
  • Long-term exposure to PM2.5 is associated with a 17% increased risk of hospitalization in PDD patients.
  • Air pollutants can cross the blood-brain barrier, potentially leading to neurotoxic effects.
  • Environmental factors, including air pollution, may drive primary prevention strategies for neurodegenerative diseases.
  • The study utilized a robust population-based dataset from Denmark to assess the risks associated with air pollution.

Clinical Implications

Healthcare professionals should consider environmental exposures, such as air pollution, when assessing risk factors for DLB and PDD. This awareness may inform preventive strategies and patient management in clinical practice.

Conclusion

The findings underscore the importance of investigating environmental factors in the context of neurodegenerative diseases, particularly α-synucleinopathies. Further research is warranted to explore these associations and their implications for public health.

Related Resources & Content

  1. Acta Neuropathologica, 2025 -- Spatially resolved molecular signatures of Lewy body dementia
  2. conexiant, 2025 -- CSF Biomarker May Support Lewy Body Diagnosis
  3. Brain, 2025 -- The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients
  4. Dementia with Lewy Bodies Guidelines, 2025 -- Guidelines Summary
  5. Lewy body dementia promotion by air pollutants, 2025 -- PubMed
  6. Brain — Cholinergic System Degeneration in Early and Prodromal Stages of Parkinson’s Disease: Implications for Current and Future Disease Progression
  7. ALZHEIMER’S DISEASE-RELATED DEMENTIAS
  8. Dementia with Lewy Bodies Guidelines: Guidelines Summary
  9. Lewy body dementia promotion by air pollutants - PubMed

Original Source(s)

Related Content